These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8905573)
1. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism. Monshouwer M; Witkamp RF; Nijmeijer SM; Van Leengoed LA; Vernooy HC; Verheijden JH; Van Miert AS J Vet Pharmacol Ther; 1996 Oct; 19(5):382-88. PubMed ID: 8905573 [TBL] [Abstract][Full Text] [Related]
2. The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits. Saitoh T; Kokue E; Shimoda M J Vet Pharmacol Ther; 1999 Apr; 22(2):87-95. PubMed ID: 10372593 [TBL] [Abstract][Full Text] [Related]
3. Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs. Monshouwer M; Witkamp RF; Nijmeijer SM; Van Leengoed LA; Verheijden JH; Van Miert AS Drug Metab Dispos; 1995 Jan; 23(1):44-7. PubMed ID: 7720523 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of decrease in levels of hepatic P450 isozymes induced by intracerebral endotoxin: independence from sympathetic nervous and adrenocortical systems. Shimamoto Y; Kitamura H; Iwai M; Saito M; Kazusaka A; Fujita S Arch Toxicol; 1999 Feb; 73(1):41-9. PubMed ID: 10207613 [TBL] [Abstract][Full Text] [Related]
5. Differential alterations in levels of hepatic microsomal cytochrome P450 isozymes following intracerebroventricular injection of bacterial lipopolysaccharide in rats. Shimamoto Y; Kitamura H; Hoshi H; Kazusaka A; Funae Y; Imaoka S; Saito M; Fujita S Arch Toxicol; 1998; 72(8):492-8. PubMed ID: 9765064 [TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous administration of lipopolysaccharide on cytochrome P450 isoforms and hepatic drug metabolizing enzymes in swine. Myers MJ; Farrell DE; Howard KD; Kawalek JC Am J Vet Res; 2010 Mar; 71(3):342-8. PubMed ID: 20187837 [TBL] [Abstract][Full Text] [Related]
7. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450. Spaethe SM; Jollow DJ Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604 [TBL] [Abstract][Full Text] [Related]
8. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. Shedlofsky SI; Israel BC; McClain CJ; Hill DB; Blouin RA J Clin Invest; 1994 Dec; 94(6):2209-14. PubMed ID: 7989576 [TBL] [Abstract][Full Text] [Related]
9. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain. Renton KW; Nicholson TE J Pharmacol Exp Ther; 2000 Aug; 294(2):524-30. PubMed ID: 10900228 [TBL] [Abstract][Full Text] [Related]
10. Effect of dietary ascorbic acid on the hepatic microsomal mixed function oxidase system in liver of chicks treated with Escherichia coli lipopolysaccharide. Takahashi K; Akiba Y; Tamura K Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Nov; 118(3):301-4. PubMed ID: 9467882 [TBL] [Abstract][Full Text] [Related]
11. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes. Menicagli S; Lippi A; Criscuoli M; Gervasi PG Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039 [TBL] [Abstract][Full Text] [Related]
12. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat. Abdulla D; Goralski KB; Renton KW Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892 [TBL] [Abstract][Full Text] [Related]
13. Depression of hepatic drug metabolism in endotoxin-treated and sarcoma-bearing mice. Bertini R; Gervasi PG; Longo V; Ghezzi P Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):223-31. PubMed ID: 1604046 [TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Chen YL; Florentin I; Batt AM; Ferrari L; Giroud JP; Chauvelot-Moachon L Biochem Pharmacol; 1992 Jul; 44(1):137-48. PubMed ID: 1632828 [TBL] [Abstract][Full Text] [Related]
15. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. Butler AM; Murray M J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313 [TBL] [Abstract][Full Text] [Related]
16. Putrescine decreases cytochrome P450 3A4 levels during liver regeneration in the rat. Favre C; Monti JA; Scapini C; Pellegrino J; Carnovale CE; Carrillo MC J Hepatol; 1998 Apr; 28(4):700-8. PubMed ID: 9566840 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of B- and T-lymphocyte mitogens on cytochrome P450 in mice. Jeong HG Toxicol Lett; 1999 Jan; 104(1-2):57-64. PubMed ID: 10048750 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response. Warren GW; van Ess PJ; Watson AM; Mattson MP; Blouin RA J Interferon Cytokine Res; 2001 Oct; 21(10):821-6. PubMed ID: 11710994 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899 [TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450. Chapman DE; Holbrook DJ; Chaney SG; Hall IH; Lee KH Biochem Pharmacol; 1991 Jan; 41(2):229-35. PubMed ID: 1989634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]